Overview of Technegas for Radiopharmacies

An Introduction to Technegas® with Cyclomedica CEO James McBrayer

In this video, Cyclomedica CEO James McBrayer introduces the powerful clinical value of Technegas®, explaining how its nanoparticle formulation enables precise, high-resolution ventilation imaging. With a proven track record in over 65 countries and now FDA-approved, Technegas® offers a trusted, efficient solution for diagnosing pulmonary embolism and other respiratory conditions. The video highlights not only its diagnostic strength but also its simplicity, speed, and seamless integration into nuclear medicine workflows.